Advances in anticancer effect of NVP-BEZ235 and its mechanism

Zhen LIU,Fenghou GAO

DOI: https://doi.org/10.3781/j.issn.1000-7431.2015.55.544

2015-01-01

Tumori

Abstract:The phosphatidylinositol 3-kinase (PI3K)/protein kinase B (PKB, Akt)/ mammalian target of rapamycin (mTOR) signaling pathway is highly activated in malignant tumors, and this pathway is closely related to the proliferation, differentiation, apoptosis, adhesion, migration and metabolism of cancer cells. NVP-BEZ235, as a small molecule inhibitor and dual protein kinase inhibitior, targets both PI3K and mTOR signaling pathways. In recent years, numerous studies have confirmed that NVP-BEZ235 has significant anticancer effect in more than 20 human tumor cells and animal models of cancer through multiple mechanisms. This paper reviews the anticancer effects of NVP-BEZ235 about the cell proliferation, cycle, apoptosis, autophagy, differentiation, angiogenesis and epithelial mesenchymal transition (EMT). DOI:10.3781/j.issn.1000-7431.2015.55.544